$19.00
2.0211.9%
Ult. Agg.: Nov 6, 4:00 PM
The average analyst price target for Apollomics is $850, 3928.4% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $200 to $1,700. The latest change came on May 8, 2024, when HC Wainwright & Co. lowered its price target on Apollomics from $500 to $200 and kept a Buy rating.
Price Target Range — 2 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months